OGR for AMGEN USA INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part D and Medicare Part B reimbursement and coverage issues. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.2693, To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement. S.283, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2019. Executive Orders on Lowering Drug Prices by Putting America First (E.O. 13947, E.O. 13948).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEAN AGUILLEN | — |
| MOSES MERCADO | — |
| JEROME MURRAY New | Chief of Staff, Rep. Stacey Plaskett; Legislative Director, Rep. G.K. Butterfield; Associate Director, Democratic Steering and Outreach Committee, Sen. Harry Reid; Legislative Director, Rep. Chaka Fattah; Staff Assistant, Rep. Chaka Fattah |
| KARISSA WILLHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.